Taken together, the increased KYN and IDO1/TDO2 indicate that TRY metabolic pathway initialized by IDO1/TDO2 may exert import role in the progression of EMPD and paired metabolomic and transcriptomic analyses should be performed to confirm our findings in a large EMPD samples. Here, IDO1 is linked to extramammary Paget disease.